nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—FMO3—metabolic syndrome X	0.637	0.77	CbGaD
Olanzapine—HTR2C—metabolic syndrome X	0.133	0.16	CbGaD
Olanzapine—ALB—metabolic syndrome X	0.0578	0.0698	CbGaD
Olanzapine—HTR7—sympathetic nervous system—metabolic syndrome X	0.00382	0.078	CbGeAlD
Olanzapine—HTR2A—arteriole—metabolic syndrome X	0.00374	0.0763	CbGeAlD
Olanzapine—HTR7—autonomic nervous system—metabolic syndrome X	0.00257	0.0524	CbGeAlD
Olanzapine—HTR2A—sympathetic nervous system—metabolic syndrome X	0.00238	0.0486	CbGeAlD
Olanzapine—HTR1B—artery—metabolic syndrome X	0.00189	0.0386	CbGeAlD
Olanzapine—HTR1D—artery—metabolic syndrome X	0.00183	0.0373	CbGeAlD
Olanzapine—HTR2A—autonomic nervous system—metabolic syndrome X	0.0016	0.0327	CbGeAlD
Olanzapine—Clozapine—FMO3—metabolic syndrome X	0.00156	0.496	CrCbGaD
Olanzapine—HTR1B—blood vessel—metabolic syndrome X	0.00147	0.03	CbGeAlD
Olanzapine—HTR7—artery—metabolic syndrome X	0.00146	0.0297	CbGeAlD
Olanzapine—HTR1D—blood vessel—metabolic syndrome X	0.00142	0.0291	CbGeAlD
Olanzapine—HTR7—endothelium—metabolic syndrome X	0.00123	0.0251	CbGeAlD
Olanzapine—HTR7—blood vessel—metabolic syndrome X	0.00113	0.0232	CbGeAlD
Olanzapine—HRH2—cardiovascular system—metabolic syndrome X	0.000995	0.0203	CbGeAlD
Olanzapine—FMO3—adipose tissue—metabolic syndrome X	0.000986	0.0201	CbGeAlD
Olanzapine—HTR2A—artery—metabolic syndrome X	0.000908	0.0185	CbGeAlD
Olanzapine—ADRA1B—kidney—metabolic syndrome X	0.00085	0.0174	CbGeAlD
Olanzapine—H1F0—cardiovascular system—metabolic syndrome X	0.00082	0.0167	CbGeAlD
Olanzapine—H1F0—kidney—metabolic syndrome X	0.000802	0.0164	CbGeAlD
Olanzapine—HTR2A—endothelium—metabolic syndrome X	0.000767	0.0157	CbGeAlD
Olanzapine—H1F0—adipose tissue—metabolic syndrome X	0.000723	0.0148	CbGeAlD
Olanzapine—HTR2A—blood vessel—metabolic syndrome X	0.000707	0.0144	CbGeAlD
Olanzapine—FMO3—liver—metabolic syndrome X	0.000692	0.0141	CbGeAlD
Olanzapine—HTR1B—cardiovascular system—metabolic syndrome X	0.000656	0.0134	CbGeAlD
Olanzapine—CHRM2—cardiovascular system—metabolic syndrome X	0.000653	0.0133	CbGeAlD
Olanzapine—HTR1D—cardiovascular system—metabolic syndrome X	0.000635	0.013	CbGeAlD
Olanzapine—HTR1D—kidney—metabolic syndrome X	0.000622	0.0127	CbGeAlD
Olanzapine—HRH2—liver—metabolic syndrome X	0.000616	0.0126	CbGeAlD
Olanzapine—CHRM1—cardiovascular system—metabolic syndrome X	0.000594	0.0121	CbGeAlD
Olanzapine—HTR2B—cardiovascular system—metabolic syndrome X	0.000591	0.0121	CbGeAlD
Olanzapine—HTR1A—cardiovascular system—metabolic syndrome X	0.000529	0.0108	CbGeAlD
Olanzapine—HTR2B—adipose tissue—metabolic syndrome X	0.000521	0.0106	CbGeAlD
Olanzapine—CHRM3—kidney—metabolic syndrome X	0.00052	0.0106	CbGeAlD
Olanzapine—H1F0—liver—metabolic syndrome X	0.000507	0.0104	CbGeAlD
Olanzapine—HTR7—cardiovascular system—metabolic syndrome X	0.000506	0.0103	CbGeAlD
Olanzapine—Amoxapine—HTR2C—metabolic syndrome X	0.000495	0.158	CrCbGaD
Olanzapine—HTR7—kidney—metabolic syndrome X	0.000495	0.0101	CbGeAlD
Olanzapine—ADRA1A—cardiovascular system—metabolic syndrome X	0.000488	0.00997	CbGeAlD
Olanzapine—CHRM3—adipose tissue—metabolic syndrome X	0.000469	0.00957	CbGeAlD
Olanzapine—ABCB1—blood vessel—metabolic syndrome X	0.000464	0.00947	CbGeAlD
Olanzapine—ADRA2C—kidney—metabolic syndrome X	0.000455	0.00929	CbGeAlD
Olanzapine—ORM1—liver—metabolic syndrome X	0.000433	0.00884	CbGeAlD
Olanzapine—ADRA1A—adipose tissue—metabolic syndrome X	0.00043	0.00879	CbGeAlD
Olanzapine—ADRA2C—adipose tissue—metabolic syndrome X	0.00041	0.00838	CbGeAlD
Olanzapine—Loxapine—HTR2C—metabolic syndrome X	0.000387	0.123	CrCbGaD
Olanzapine—CYP2C9—cardiovascular system—metabolic syndrome X	0.000383	0.00782	CbGeAlD
Olanzapine—ALB—liver—metabolic syndrome X	0.00038	0.00775	CbGeAlD
Olanzapine—Quetiapine—HTR2C—metabolic syndrome X	0.000377	0.12	CrCbGaD
Olanzapine—HRH1—adipose tissue—metabolic syndrome X	0.000333	0.0068	CbGeAlD
Olanzapine—ADRA2A—adipose tissue—metabolic syndrome X	0.000327	0.00668	CbGeAlD
Olanzapine—Clozapine—HTR2C—metabolic syndrome X	0.000325	0.103	CrCbGaD
Olanzapine—HTR2A—cardiovascular system—metabolic syndrome X	0.000316	0.00644	CbGeAlD
Olanzapine—HTR7—liver—metabolic syndrome X	0.000313	0.00639	CbGeAlD
Olanzapine—HTR2A—kidney—metabolic syndrome X	0.000309	0.0063	CbGeAlD
Olanzapine—CYP2C19—liver—metabolic syndrome X	0.000306	0.00624	CbGeAlD
Olanzapine—ADRA1A—liver—metabolic syndrome X	0.000302	0.00616	CbGeAlD
Olanzapine—ADRA2C—liver—metabolic syndrome X	0.000288	0.00587	CbGeAlD
Olanzapine—CYP3A4—kidney—metabolic syndrome X	0.000286	0.00584	CbGeAlD
Olanzapine—CYP2D6—kidney—metabolic syndrome X	0.000281	0.00574	CbGeAlD
Olanzapine—CYP1A2—liver—metabolic syndrome X	0.00025	0.0051	CbGeAlD
Olanzapine—CYP2C9—liver—metabolic syndrome X	0.000237	0.00484	CbGeAlD
Olanzapine—ABCB1—cardiovascular system—metabolic syndrome X	0.000207	0.00422	CbGeAlD
Olanzapine—ABCB1—kidney—metabolic syndrome X	0.000202	0.00413	CbGeAlD
Olanzapine—HTR2A—liver—metabolic syndrome X	0.000195	0.00399	CbGeAlD
Olanzapine—ABCB1—adipose tissue—metabolic syndrome X	0.000182	0.00372	CbGeAlD
Olanzapine—CYP3A4—liver—metabolic syndrome X	0.000181	0.00369	CbGeAlD
Olanzapine—CYP2D6—liver—metabolic syndrome X	0.000178	0.00363	CbGeAlD
Olanzapine—ABCB1—liver—metabolic syndrome X	0.000128	0.00261	CbGeAlD
Olanzapine—CHRM1—Signaling Pathways—INS—metabolic syndrome X	4.28e-06	3.56e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—APOA1—metabolic syndrome X	4.27e-06	3.55e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—INS—metabolic syndrome X	4.26e-06	3.55e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—LPL—metabolic syndrome X	4.26e-06	3.54e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	4.23e-06	3.52e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	4.23e-06	3.52e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—IL6—metabolic syndrome X	4.23e-06	3.51e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—NOS3—metabolic syndrome X	4.23e-06	3.51e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—INS—metabolic syndrome X	4.22e-06	3.51e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CCL2—metabolic syndrome X	4.22e-06	3.51e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—LPL—metabolic syndrome X	4.22e-06	3.51e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	4.22e-06	3.51e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	4.21e-06	3.5e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CCL2—metabolic syndrome X	4.21e-06	3.5e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CCL2—metabolic syndrome X	4.2e-06	3.49e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling by GPCR—AKT1—metabolic syndrome X	4.19e-06	3.48e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	4.16e-06	3.46e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—NOS3—metabolic syndrome X	4.16e-06	3.46e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CCL2—metabolic syndrome X	4.16e-06	3.46e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IGF1—metabolic syndrome X	4.15e-06	3.45e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling by GPCR—AKT1—metabolic syndrome X	4.15e-06	3.45e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	4.14e-06	3.45e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IGF1—metabolic syndrome X	4.14e-06	3.44e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IGF1—metabolic syndrome X	4.13e-06	3.43e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—NOS3—metabolic syndrome X	4.1e-06	3.41e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	4.09e-06	3.4e-05	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—PTGS2—metabolic syndrome X	4.09e-06	3.4e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PPARA—metabolic syndrome X	4.09e-06	3.4e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	4.09e-06	3.4e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IGF1—metabolic syndrome X	4.09e-06	3.4e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	4.07e-06	3.39e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—CD36—metabolic syndrome X	4.05e-06	3.36e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	4.02e-06	3.34e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—CD36—metabolic syndrome X	4.01e-06	3.34e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PPARA—metabolic syndrome X	3.99e-06	3.32e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	3.98e-06	3.31e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GOT2—metabolic syndrome X	3.98e-06	3.31e-05	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—AKT1—metabolic syndrome X	3.97e-06	3.3e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—AGT—metabolic syndrome X	3.96e-06	3.29e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—AKT1—metabolic syndrome X	3.95e-06	3.29e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	3.95e-06	3.29e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—SERPINE1—metabolic syndrome X	3.94e-06	3.28e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—SERPINE1—metabolic syndrome X	3.93e-06	3.27e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—SERPINE1—metabolic syndrome X	3.92e-06	3.26e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	3.91e-06	3.25e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—TGFB1—metabolic syndrome X	3.9e-06	3.24e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—AKT1—metabolic syndrome X	3.9e-06	3.24e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—TGFB1—metabolic syndrome X	3.9e-06	3.24e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—APOE—metabolic syndrome X	3.88e-06	3.23e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—SERPINE1—metabolic syndrome X	3.88e-06	3.23e-05	CbGpPWpGaD
Olanzapine—ADRA2B—GPCR downstream signaling—AKT1—metabolic syndrome X	3.88e-06	3.22e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—TGFB1—metabolic syndrome X	3.87e-06	3.22e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	3.87e-06	3.22e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—AGT—metabolic syndrome X	3.87e-06	3.21e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	3.85e-06	3.2e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—APOA1—metabolic syndrome X	3.84e-06	3.19e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	3.83e-06	3.19e-05	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—IL6—metabolic syndrome X	3.83e-06	3.19e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—IL6—metabolic syndrome X	3.82e-06	3.17e-05	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—IL6—metabolic syndrome X	3.81e-06	3.17e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—TGFB1—metabolic syndrome X	3.79e-06	3.15e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—APOE—metabolic syndrome X	3.79e-06	3.15e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	3.79e-06	3.15e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—APOB—metabolic syndrome X	3.78e-06	3.14e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	3.77e-06	3.14e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PPARG—metabolic syndrome X	3.77e-06	3.13e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—NOS3—metabolic syndrome X	3.76e-06	3.13e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PPARA—metabolic syndrome X	3.76e-06	3.13e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	3.75e-06	3.12e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—NOS3—metabolic syndrome X	3.75e-06	3.12e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—APOA1—metabolic syndrome X	3.74e-06	3.11e-05	CbGpPWpGaD
Olanzapine—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	3.74e-06	3.11e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—NOS3—metabolic syndrome X	3.74e-06	3.11e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—TGFB1—metabolic syndrome X	3.73e-06	3.1e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PPARA—metabolic syndrome X	3.73e-06	3.1e-05	CbGpPWpGaD
Olanzapine—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	3.72e-06	3.1e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—NOS3—metabolic syndrome X	3.7e-06	3.08e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—INS—metabolic syndrome X	3.69e-06	3.07e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	3.69e-06	3.07e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	3.68e-06	3.06e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—TGFB1—metabolic syndrome X	3.68e-06	3.06e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	3.68e-06	3.06e-05	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—AKT1—metabolic syndrome X	3.67e-06	3.05e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	3.66e-06	3.05e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—AGT—metabolic syndrome X	3.64e-06	3.03e-05	CbGpPWpGaD
Olanzapine—ADRA2C—GPCR downstream signaling—AKT1—metabolic syndrome X	3.62e-06	3.01e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—AGT—metabolic syndrome X	3.61e-06	3e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—LPL—metabolic syndrome X	3.61e-06	3e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	3.59e-06	2.99e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—APOE—metabolic syndrome X	3.57e-06	2.97e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—IL6—metabolic syndrome X	3.56e-06	2.96e-05	CbGpPWpGaD
Olanzapine—ADRA1B—GPCR downstream signaling—AKT1—metabolic syndrome X	3.56e-06	2.96e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—TGFB1—metabolic syndrome X	3.56e-06	2.96e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	3.55e-06	2.95e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	3.55e-06	2.95e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—APOE—metabolic syndrome X	3.54e-06	2.94e-05	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—AKT1—metabolic syndrome X	3.54e-06	2.94e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—APOA1—metabolic syndrome X	3.53e-06	2.93e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—TGFB1—metabolic syndrome X	3.52e-06	2.93e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—AKT1—metabolic syndrome X	3.52e-06	2.93e-05	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—AKT1—metabolic syndrome X	3.51e-06	2.92e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—IL6—metabolic syndrome X	3.51e-06	2.92e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—APOA1—metabolic syndrome X	3.5e-06	2.91e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GGT1—metabolic syndrome X	3.44e-06	2.86e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GOT1—metabolic syndrome X	3.44e-06	2.86e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	3.43e-06	2.85e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—CD36—metabolic syndrome X	3.43e-06	2.85e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	3.4e-06	2.83e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PPARG—metabolic syndrome X	3.38e-06	2.81e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	3.38e-06	2.81e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—TGFB1—metabolic syndrome X	3.36e-06	2.79e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—INS—metabolic syndrome X	3.32e-06	2.76e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—TGFB1—metabolic syndrome X	3.31e-06	2.75e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PPARG—metabolic syndrome X	3.3e-06	2.74e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—AKT1—metabolic syndrome X	3.29e-06	2.73e-05	CbGpPWpGaD
Olanzapine—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	3.29e-06	2.73e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—NOS3—metabolic syndrome X	3.24e-06	2.69e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—INS—metabolic syndrome X	3.24e-06	2.69e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—AKT1—metabolic syndrome X	3.24e-06	2.69e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	3.23e-06	2.69e-05	CbGpPWpGaD
Olanzapine—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	3.23e-06	2.69e-05	CbGpPWpGaD
Olanzapine—HRH1—GPCR downstream signaling—AKT1—metabolic syndrome X	3.23e-06	2.68e-05	CbGpPWpGaD
Olanzapine—CHRM1—GPCR downstream signaling—AKT1—metabolic syndrome X	3.22e-06	2.67e-05	CbGpPWpGaD
Olanzapine—CHRM3—GPCR downstream signaling—AKT1—metabolic syndrome X	3.2e-06	2.66e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PPARA—metabolic syndrome X	3.19e-06	2.65e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	3.18e-06	2.65e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—IL6—metabolic syndrome X	3.17e-06	2.64e-05	CbGpPWpGaD
Olanzapine—CHRM2—GPCR downstream signaling—AKT1—metabolic syndrome X	3.17e-06	2.64e-05	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	3.17e-06	2.63e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—IL6—metabolic syndrome X	3.16e-06	2.63e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—IL6—metabolic syndrome X	3.15e-06	2.62e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—IL6—metabolic syndrome X	3.12e-06	2.6e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	3.12e-06	2.59e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PPARG—metabolic syndrome X	3.11e-06	2.59e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—AGT—metabolic syndrome X	3.09e-06	2.57e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PPARG—metabolic syndrome X	3.08e-06	2.56e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—INS—metabolic syndrome X	3.05e-06	2.54e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—ALB—metabolic syndrome X	3.04e-06	2.53e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—APOE—metabolic syndrome X	3.02e-06	2.51e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—INS—metabolic syndrome X	3.02e-06	2.51e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TGFB1—metabolic syndrome X	2.99e-06	2.49e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—APOA1—metabolic syndrome X	2.99e-06	2.49e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	2.98e-06	2.48e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—ALB—metabolic syndrome X	2.97e-06	2.47e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PTGS2—metabolic syndrome X	2.96e-06	2.46e-05	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	2.94e-06	2.45e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—IL6—metabolic syndrome X	2.94e-06	2.44e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—IL6—metabolic syndrome X	2.94e-06	2.44e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	2.94e-06	2.44e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—AKT1—metabolic syndrome X	2.93e-06	2.44e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—AKT1—metabolic syndrome X	2.92e-06	2.43e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—IL6—metabolic syndrome X	2.92e-06	2.43e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—APOB—metabolic syndrome X	2.92e-06	2.42e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—AKT1—metabolic syndrome X	2.91e-06	2.42e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—NOS3—metabolic syndrome X	2.91e-06	2.42e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	2.89e-06	2.41e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	2.89e-06	2.4e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—AKT1—metabolic syndrome X	2.88e-06	2.4e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	2.87e-06	2.39e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	2.87e-06	2.39e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—IL6—metabolic syndrome X	2.86e-06	2.37e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—NOS3—metabolic syndrome X	2.84e-06	2.36e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	2.84e-06	2.36e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—IL6—metabolic syndrome X	2.81e-06	2.34e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—ALB—metabolic syndrome X	2.8e-06	2.32e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TGFB1—metabolic syndrome X	2.79e-06	2.32e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—LPL—metabolic syndrome X	2.78e-06	2.32e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—IL6—metabolic syndrome X	2.77e-06	2.31e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—ALB—metabolic syndrome X	2.77e-06	2.3e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TGFB1—metabolic syndrome X	2.75e-06	2.29e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—AKT1—metabolic syndrome X	2.71e-06	2.25e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—AKT1—metabolic syndrome X	2.71e-06	2.25e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—AKT1—metabolic syndrome X	2.69e-06	2.24e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—IL6—metabolic syndrome X	2.68e-06	2.23e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—NOS3—metabolic syndrome X	2.67e-06	2.22e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	2.67e-06	2.22e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PTGS2—metabolic syndrome X	2.66e-06	2.21e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—IL6—metabolic syndrome X	2.66e-06	2.21e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—NOS3—metabolic syndrome X	2.65e-06	2.2e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CD36—metabolic syndrome X	2.65e-06	2.2e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—AKT1—metabolic syndrome X	2.63e-06	2.19e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PPARG—metabolic syndrome X	2.63e-06	2.19e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PTGS2—metabolic syndrome X	2.6e-06	2.16e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—AKT1—metabolic syndrome X	2.59e-06	2.16e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—INS—metabolic syndrome X	2.58e-06	2.15e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—AKT1—metabolic syndrome X	2.56e-06	2.13e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	2.54e-06	2.11e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—IL6—metabolic syndrome X	2.53e-06	2.1e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—IL6—metabolic syndrome X	2.5e-06	2.08e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	2.49e-06	2.07e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TGFB1—metabolic syndrome X	2.49e-06	2.07e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TGFB1—metabolic syndrome X	2.48e-06	2.06e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—AKT1—metabolic syndrome X	2.48e-06	2.06e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TGFB1—metabolic syndrome X	2.47e-06	2.06e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PPARA—metabolic syndrome X	2.46e-06	2.05e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—AKT1—metabolic syndrome X	2.45e-06	2.04e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TGFB1—metabolic syndrome X	2.45e-06	2.04e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	2.45e-06	2.03e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	2.44e-06	2.03e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	2.42e-06	2.02e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—AGT—metabolic syndrome X	2.38e-06	1.98e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—ALB—metabolic syndrome X	2.37e-06	1.97e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—AKT1—metabolic syndrome X	2.33e-06	1.94e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—APOE—metabolic syndrome X	2.33e-06	1.94e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—AKT1—metabolic syndrome X	2.32e-06	1.93e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—APOA1—metabolic syndrome X	2.31e-06	1.92e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—AKT1—metabolic syndrome X	2.3e-06	1.91e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	2.27e-06	1.89e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—NOS3—metabolic syndrome X	2.27e-06	1.88e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—IL6—metabolic syndrome X	2.25e-06	1.87e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	2.18e-06	1.81e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	2.16e-06	1.8e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—IL6—metabolic syndrome X	2.11e-06	1.75e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—AKT1—metabolic syndrome X	2.08e-06	1.73e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	2.07e-06	1.72e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—IL6—metabolic syndrome X	2.07e-06	1.72e-05	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—AKT1—metabolic syndrome X	2.06e-06	1.71e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PPARG—metabolic syndrome X	2.03e-06	1.69e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	2.01e-06	1.67e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	2e-06	1.66e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—INS—metabolic syndrome X	1.99e-06	1.66e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—AKT1—metabolic syndrome X	1.94e-06	1.61e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—AKT1—metabolic syndrome X	1.91e-06	1.59e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IL6—metabolic syndrome X	1.91e-06	1.59e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—AKT1—metabolic syndrome X	1.89e-06	1.57e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	1.88e-06	1.56e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IL6—metabolic syndrome X	1.88e-06	1.56e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IL6—metabolic syndrome X	1.87e-06	1.55e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IL6—metabolic syndrome X	1.86e-06	1.55e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IL6—metabolic syndrome X	1.85e-06	1.53e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	1.84e-06	1.53e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ALB—metabolic syndrome X	1.83e-06	1.52e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	1.76e-06	1.47e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—NOS3—metabolic syndrome X	1.75e-06	1.45e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	1.73e-06	1.44e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—AKT1—metabolic syndrome X	1.73e-06	1.44e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—AKT1—metabolic syndrome X	1.72e-06	1.43e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—AKT1—metabolic syndrome X	1.72e-06	1.43e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	1.71e-06	1.42e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—AKT1—metabolic syndrome X	1.7e-06	1.42e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	1.7e-06	1.41e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	1.6e-06	1.33e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	1.58e-06	1.31e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—AKT1—metabolic syndrome X	1.49e-06	1.24e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—AKT1—metabolic syndrome X	1.34e-06	1.11e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—AKT1—metabolic syndrome X	1.3e-06	1.08e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—AKT1—metabolic syndrome X	1.23e-06	1.02e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—AKT1—metabolic syndrome X	1.22e-06	1.01e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—AKT1—metabolic syndrome X	1.04e-06	8.66e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—AKT1—metabolic syndrome X	8.04e-07	6.68e-06	CbGpPWpGaD
